NHS National Framework for Transition products (Nilotinib and Ticagrelor)
What the buyer wrote
Project title: NHS National Framework for Transition products (Nilotinib and Ticagrelor) commencing 1st September 2025 Offer reference number: CM/TNS/24/5721 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/24/5721/01 - Nilotinib and Ticagrelor Lot 1 DCE/DNW/DNE: 01/09/2025 to 31/01/2027 (17 months) Lot 2 DLN/DLS/DSW: 01/09/2025 to 31/01/2027 (17 months) Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England Please note that the contract had erroneously been advertised as an open…
Bid for this and lost? There is a short window in which the decision can be questioned.
Details
- What the buyer calls it
- NHS National Framework for Transition products (Nilotinib and Ticagrelor)
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- goods
- Framework
- Yes: joining it lets you bid for call-offs without a new tender each time
- Work starts
- 31 Aug 2025
- Work ends
- 31 Jan 2027
- Where
- in the North East, in the North West, in the East Midlands, in the West Midlands, in the East of England, in the South East, in the South West, in Yorkshire and The Humber, in London
- Kind of work
- Pharmacy and medicines
Who the buyer named
The buyer published a contact address on this notice. Questions closed on 2 Jun 2025, 13:00 BST.
